IGEA PHARMA N.V. Inactive Instrument
IGEA Pharma N.V.
Equities
IGPH
NL0012768675
Medical Equipment, Supplies & Distribution
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
IGEA Pharma NV is a biopharmaceutical company based in the Netherlands. The Company focuses on research and development of biomedical solutions for the prevention of diabetes and Alzheimer's disease. Its offering portfolio includes medical testing devices and dietary supplements. The Company develops ALZ-1 Test, a blood test to measure and control level of free copper, also known as Free Copper II or Non-Ceruloplasmin Copper in the bloodstream, which is a major recognized modifiable risk factor for the Alzheimer's disease. The Company offers its services in the Netherlands.
Calendar
2024-07-11
- Q4 2023 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -1.59% | 12.58B | |
| -17.62% | 6.82B | |
| -3.93% | 5.14B | |
| -6.68% | 4.22B | |
| +1.34% | 4.21B | |
| -48.68% | 3.47B | |
| +7.09% | 2.65B | |
| -13.71% | 2.25B | |
| -2.82% | 1.69B |
